Postmarketing surveillance

The review of adverse reactions to drugs and medical technologies that occurs after these agents are released for sale and use. Nurses, pharmacists, physicians, and other practioners participate in this process by recording their observations on the adverse effects of drugs to the Food and Drug Administration, which accumulates this survey data and issues warnings to practitioners when needed.


 


Posted

in

by

Tags: